| Schedule of liabilities to be presented on balance sheet at fair value |
| Schedule of liabilities to be presented on balance sheet at fair value |
|
|
|
|
|
|
|
|
| Description |
|
Fair Value
As of
December 31, 2025 |
|
Fair Value Measurements at
December 31, 2025
Using Fair Value Hierarchy |
| |
|
|
|
Level 1 |
|
Level 2 |
|
Level 3 |
| Conversion feature on convertible notes |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
| Description | |
Fair Value
As of
June 30, 2026 | |
Fair Value Measurements at
June 30, 2026
Using Fair Value Hierarchy |
| | |
| |
Level 1 | |
Level 2 | |
Level 3 |
| Conversion feature on convertible notes | |
$ | 412,800 | | |
$ | 412,800 | | |
$ | — | | |
$ | — | |
|
| Schedule of potentially- dilutive shares |
| Schedule of potentially- dilutive shares |
|
|
|
|
|
|
|
|
| |
|
June 30, 2026 |
|
December 31,
2025 |
| Basic outstanding common stock |
|
|
24,417,866,769 |
|
|
|
20,217,870,775 |
|
| Series B preferred stock |
|
|
150,000 |
|
|
|
150,000 |
|
| Series C preferred stock |
|
|
385,000 |
|
|
|
385,000 |
|
| Series H preferred stock |
|
|
1,000,000 |
|
|
|
1,000,000 |
|
| Series I preferred stock |
|
|
10,000,000,000 |
|
|
|
10,000,000,000 |
|
| Convertible notes |
|
|
637,845,962,838 |
|
|
|
623,636,065,729 |
|
| Total |
|
|
672,265,364,607 |
|
|
|
653,855,471,504 |
|
|